WaitingWell, it's just 13 days until Nov 15. What we hear by then, if anything, could be interesting.
On the mCRPC trial with zen3694 my guess is that it is far to early to hear any news on that.
With rvx-208 (apabetalone) it's going to be mid to late 2017 for the futility findings.
But if a new licensing deal is announced by Nov 15 it could be very interesting depending on the new partner...it may provide a solution to the LOC but I think that will just be renewed. Or it could give clues as to where Don is taking this business. Perhaps he will find another downstream partner.
At any rate we had a big buy in in Sept and a nice ramp up in the share price and this sure hints at something significant.
Just rambling here in a vacuum.
Cheers
Toinv